Palmerini, Emanuela
Peta, Giuliano
Tuzzato, Gianmarco
Funding for this research was provided by:
Daiichi Sankyo, Inc.
Article History
Received: 15 May 2024
Accepted: 30 July 2024
First Online: 19 August 2024
Declarations
:
: Emanuela Palmerini has served on advisory boards for Daiichi Sankyo, Inc., Deciphera Pharmaceuticals, EUSA Pharma, and SynOx Therapeutics. Giuliano Peta and Gianmarco Tuzzato report no financial competing interests.
: The patient provided written informed consent for the publication of this case report and accompanying images.